Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:58 PM
Ignite Modification Date:
2025-12-24 @ 11:58 PM
NCT ID:
NCT05962658
Eligibility Criteria:
Inclusion Criteria:
* widespread pain index (WPI) ≥ 7;
* symptom severity scale (SS) = 5;
* WPI between 4-6 and (iv) SS ≥ 9;
* generalized pain, as defined as pain in at least 4 regions of the body;
* having been diagnosed with fibromyalgia at least three months ago.
Exclusion Criteria:
* autoimmune or inflammatory diseases that cause pain, such as rheumatoid arthritis, systemic lupus erythematosus, or inflammatory bowel disease;
* history of neurological or psychotic disorders;
* cognitive impairment that prevents the conduct of study procedures;
* patients with a history of abusive use of alcohol or other illicit drugs;
* patients who have any contraindication for the use of the qEEG (excessive seborrhoea, scalp infection or pediculosis).
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT05962658
Study Brief:
Protocol Section:
NCT05962658